Regenerative medicine improves quality of life

We develop technologies in a team of scientists and specialists to improve patient mobility. More than 20 years of experience and over 28,000 custom-made products prove us to be a competent and efficient partner.

Latest News

  • Octane Medical acquires B. Braun’s global orthobiologics business

    Kingston, Ontario, Canada / Melsungen, Germany, June 5th, 2024 – Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition, consisting of the two companies TETEC AG in Germany and Aesculap Biologics, LLC. in the United States, establishes Octane as an international leader in regenerative medicine.

    Read More
  • Application for central authorisation submitted to the EMA

    TETEC AG has submitted the application for central approval of a gel-based matrix-associated cartilage cell product as an Advanced Therapy Medicinal Product (ATMP) to the EMA (European Medicines Agency).

    Read More